StonvexLoading…
StonvexStonvexStonvexCore line items from NWG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | £30.24B | £29.32B | £25.38B | £16.57B |
Operating Income | £7.71B | £6.20B | £6.18B | £5.13B |
Net Income | £5.83B | £4.81B | £4.63B | £3.60B |
EPS (Diluted) | £0.67 | £0.53 | £0.48 | £0.34 |
Total Assets | £714.55B | £707.99B | £692.67B | £720.05B |
Total Liabilities | £671.94B | £668.61B | £655.49B | £683.56B |
Cash & Equivalents | £95.43B | £104.84B | £118.82B | £158.45B |
Free Cash Flow OCF − CapEx | £6.41B | £1.31B | £-18.25B | £-44.24B |
Shares Outstanding | Not available | Not available | Not available | Not available |